25.10.2023
Publications category: Inflammation
10.10.2023
A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score
23.08.2023
Predicting Reductions in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations from FEV1 – A Model-Based Meta-Analysis of Literature Data from Controlled Randomized Clinical Trials
23.08.2023
Translating Pharmacometrics to a Pharmacoeconomic Model of COPD
22.08.2023
Target engagement analysis of belimumab in patients with systemic lupus erythematosus (SLE) and primary Sjogren’s syndrome (pSS)
22.08.2023
Use of informative prior distributions from mepolizumab data to support depemokimab PKPD model analysis
14.06.2023
Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis [2]

14.06.2023
Bounded integer model-based analysis of psoriasis area and severity index in patients with moderate-to-severe plaque psoriasis receiving BI 730357
14.06.2023
Population Pharmacokinetics and Exposure-Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus

14.06.2023
Population Pharmacokinetic and Exposure-Response Models for Dapirolizumab Pegol in Patients with Systemic Lupus Erythematosus
14.06.2023